Provided by Tiger Fintech (Singapore) Pte. Ltd.

Processa Pharmaceuticals, Inc.

0.1948
+0.00633.34%
Post-market: 0.19560.0008+0.41%16:55 EDT
Volume:2.85M
Turnover:548.85K
Market Cap:5.10M
PE:-0.05
High:0.1999
Open:0.1900
Low:0.1850
Close:0.1885
Loading ...

BRIEF-Processa Pharmaceuticals Terminates Licensing Agreement With Ocuphire Pharma - SEC Filing

Reuters
·
01 Jul

BRIEF-Processa Pharmaceuticals Provides Portfolio And Business Update

Reuters
·
01 Jul

Processa Pharmaceuticals Inc - Grants Intact Therapeutics Exclusive Option to License Pcs12852

THOMSON REUTERS
·
01 Jul

Processa Pharmaceuticals Inc - Terminates Licensing Agreement With Ocuphire Pharma - SEC Filing

THOMSON REUTERS
·
01 Jul

Processa Pharmaceuticals Inc - Announces Strategic Portfolio Review and Pipeline Realignment

THOMSON REUTERS
·
01 Jul

Processa Pharmaceuticals Announces New Phase 2 Clinical Trial Enrollment for Metastatic Breast Cancer Treatment

Reuters
·
01 Jul

Processa Pharmaceuticals Provides Portfolio and Business Update

THOMSON REUTERS
·
01 Jul

Processa Pharmaceuticals Inc - Continue Enrolling Patients in Phase 2 Study of Pcs6422

THOMSON REUTERS
·
01 Jul

Processa Pharmaceuticals Inc. Reconvened Annual Shareholder Meeting

Reuters
·
01 Jul

Processa Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
30 Jun

Processa Pharmaceuticals price target lowered to $2 from $6 at H.C. Wainwright

TIPRANKS
·
30 Jun

Processa Pares Gains on Equity Offer News

Dow Jones
·
18 Jun

Processa Pharmaceuticals Prices $7 Million Public Offering

MT Newswires Live
·
18 Jun

Processa sells 28M shares at 25c in public offering

TIPRANKS
·
18 Jun

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

THOMSON REUTERS
·
18 Jun

Processa Pharmaceuticals Grants Intact Therapeutics Exclusive Option to License Gastroparesis Drug Candidate; Shares Rise

MT Newswires Live
·
17 Jun

Processa Pharmaceuticals Inc - Eligible for $452.5 Mln in Total Milestone Payments

THOMSON REUTERS
·
17 Jun

Processa Pharmaceuticals Inc - Enters Binding Term Sheet With Intact Therapeutics

THOMSON REUTERS
·
17 Jun

Maxim Group Reaffirms Their Hold Rating on Processa Pharmaceuticals (PCSA)

TIPRANKS
·
17 May

Processa Pharmaceuticals Inc expected to post a loss of 77 cents a share - Earnings Preview

Reuters
·
07 May